organization · Reporting owner
Hadley Harbor Master Investors (Cayman) L.P.
Disclosed activity across 12 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZUORA INCZUO · Entity 16054 | 10% owner | April 16, 2018 | April 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZUORA INC
Report date April 16, 2018 · Filed April 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series F Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-04-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-16 · Conversion · Disposed 1,974,048 · Balance 0 F1: The Series F Convertible Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 1,974,048 |
Reported balance
After 2018-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-04-16 · Conversion · Acquired 1,974,048 · Balance 1,974,048 F1: The Series F Convertible Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date |
Filing footnotes · ownership attribution and instrument terms
F1: The Series F Convertible Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date
Past disclosures · reporting ended (11)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Allena Pharmaceuticals, Inc.
Report date November 06, 2017 · Filed November 07, 2017
Section 16 reporting ended · disclosed 2017-11-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 757,684 |
Reported balance
After 2017-11-06 transaction · row 1
1 source rowRow 1 · 2017-11-06 · Conversion · Acquired 757,684 · Balance 757,684 F1: The Series C Convertible Preferred Stock converted into Common Stock on a 4.174-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series C Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-11-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-06 · Conversion · Disposed 3,162,573 · Balance 0 F1: The Series C Convertible Preferred Stock converted into Common Stock on a 4.174-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series C Convertible Preferred Stock converted into Common Stock on a 4.174-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.
CRISPR Therapeutics AG
Report date October 24, 2016 · Filed October 24, 2016
Section 16 reporting ended · disclosed 2016-10-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 744,380 |
Reported balance
After 2016-10-24 transaction · row 1
1 source rowRow 1 · 2016-10-24 · Conversion · Acquired 744,380 · Balance 744,380 F1: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. |
| Series B Convertible Preferred SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-10-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-24 · Conversion · Disposed 744,380 · Balance 0 F1: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date.
FORESCOUT TECHNOLOGIES, INC
Report date October 31, 2017 · Filed October 31, 2017
Section 16 reporting ended · disclosed 2017-10-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,978,749 |
Reported balance
After 2017-10-31 transaction · row 1
1 source rowRow 1 · 2017-10-31 · Conversion · Acquired 1,978,749 · Balance 1,978,749 F1: As a result of a conversion price adjustment upon the consummation of the Issuer's initial public offering, the Reporting Person's shares of the Issuer's Series G Convertible Preferred Stock converted into 1,978,749 shares of the Issuer's Common Stock. The shares had no expiration date. |
| Series G Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-10-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-31 · Conversion · Disposed 1,685,346 · Balance 0 F1: As a result of a conversion price adjustment upon the consummation of the Issuer's initial public offering, the Reporting Person's shares of the Issuer's Series G Convertible Preferred Stock converted into 1,978,749 shares of the Issuer's Common Stock. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As a result of a conversion price adjustment upon the consummation of the Issuer's initial public offering, the Reporting Person's shares of the Issuer's Series G Convertible Preferred Stock converted into 1,978,749 shares of the Issuer's Common Stock. The shares had no expiration date.
Jounce Therapeutics, Inc.
Report date February 01, 2017 · Filed February 01, 2017
Section 16 reporting ended · disclosed 2017-02-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 719,476 |
Reported balance
After 2017-02-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-02-01 · Conversion · Acquired 719,476 · Balance 719,476 F1: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. |
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-01 · Conversion · Disposed 2,654,867 · Balance 0 F1: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date.
KALA BIO, Inc.
Report date July 25, 2017 · Filed July 25, 2017
Section 16 reporting ended · disclosed 2017-07-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 888,894 |
Reported balance
After 2017-07-25 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2017-07-25 · Conversion · Acquired 888,894 · Balance 888,894 F1: The Series B-1 Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Common StockSEC Table I · non-derivative | Direct | 846,566 |
Reported balance
After 2017-07-25 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2017-07-25 · Conversion · Acquired 846,566 · Balance 846,566 F2: The Series C Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series B-1 Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-07-25 · Conversion · Disposed 4,629,629 · Balance 0 F1: The Series B-1 Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series C Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-07-25 · Conversion · Disposed 4,409,170 · Balance 0 F2: The Series C Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series B-1 Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.
F2: The Series C Convertible Preferred Stock converted into Common Stock on a 5.2083-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.
NLIGHT, INC.
Report date April 30, 2018 · Filed April 30, 2018
Section 16 reporting ended · disclosed 2018-04-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,339,734 |
Reported balance
After 2018-04-30 transaction · row 1
1 source rowRow 1 · 2018-04-30 · Conversion · Acquired 3,339,734 · Balance 3,339,734 F1: The Series G Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series G Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-04-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-04-30 · Conversion · Disposed 3,339,734 · Balance 0 F1: The Series G Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series G Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The shares had no expiration date.
Neon Therapeutics, Inc.
Report date June 29, 2018 · Filed June 29, 2018
Section 16 reporting ended · disclosed 2018-06-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 665,922 |
Reported balance
After 2018-06-29 transaction · row 1
1 source rowRow 1 · 2018-06-29 · Conversion · Acquired 665,922 · Balance 665,922 F1: The Series B Convertible Preferred Stock converted into Common Stock on a 5-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-29 · Conversion · Disposed 3,329,610 · Balance 0 F1: The Series B Convertible Preferred Stock converted into Common Stock on a 5-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series B Convertible Preferred Stock converted into Common Stock on a 5-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.
PELOTON INTERACTIVE, INC.
Report date March 24, 2020 · Filed March 26, 2020
Section 16 reporting ended · disclosed 2020-03-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 4,962,678 |
Ending reported balance
After 2020-03-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-03-24 · Sale · Disposed 434,211 · Balance 5,493,467 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.44 to $24.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Row 2 · 2020-03-25 · Sale · Disposed 254,589 · Balance 5,238,878 Row 3 · 2020-03-25 · Sale · Disposed 276,200 · Balance 4,962,678 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.44 to $24.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
PINTEREST, INC.
Report date April 23, 2019 · Filed April 23, 2019
Section 16 reporting ended · disclosed 2019-04-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series G Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-04-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-04-23 · Conversion · Disposed 696,500 · Balance 0 F1: The Series G Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 696,500 |
Reported balance
After 2019-04-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-23 · Conversion · Acquired 696,500 · Balance 696,500 F1: The Series G Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series G Preferred Stock converted into Class B Common Stock on a one-for-one basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date.
RHYTHM PHARMACEUTICALS, INC.
Report date October 10, 2017 · Filed October 10, 2017
Section 16 reporting ended · disclosed 2017-10-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 545,256 |
Reported balance
After 2017-10-10 transaction · row 1
1 source rowRow 1 · 2017-10-10 · Conversion · Acquired 545,256 · Balance 545,256 F1: The Series A Convertible Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-10-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-10 · Conversion · Disposed 5,000,000 · Balance 0 F1: The Series A Convertible Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series A Convertible Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Trade Desk, Inc.
Report date April 27, 2017 · Filed May 01, 2017
Section 16 reporting ended · disclosed 2017-05-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,723,367 |
Ending reported balance
After 2017-05-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-04-27 · Sale · Disposed 17,100 · Balance 1,782,907 Row 2 · 2017-04-28 · Sale · Disposed 3,900 · Balance 1,779,007 Row 3 · 2017-05-01 · Sale · Disposed 55,640 · Balance 1,723,367 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.41 to $37.6094, inclusive. The reporting person undertakes to provide to The Trade Desk, Inc., any security holder of The Trade Desk, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.41 to $37.6094, inclusive. The reporting person undertakes to provide to The Trade Desk, Inc., any security holder of The Trade Desk, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 30, 2017 20:13 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 122,700 | $37.84 | $4,642,563.09 |
DisclosureSEC source: 0001104659-17-020370 · a4.xml · nonDerivative · entry 2 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,710,467 Read SEC document |
| March 28, 2017 Filed Mar 30, 2017 20:13 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 38,700 | $36.35 | $1,406,923.02 |
DisclosureSEC source: 0001104659-17-020370 · a4.xml · nonDerivative · entry 1 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833,167 F1 · balance_after: All of the reporting person's previously reported Class B Common Stock has been converted to Class A Common Stock on a one-for-one basis. Accordingly, the reporting person no longer holds any Class B Common Stock. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 84,832 | $37.22 | $3,157,650.64 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 12 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,871,867 Underlying: Class A Common Stock · 84,832 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 24,200 | $37.11 | $898,149.12 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 11 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956,699 Underlying: Class A Common Stock · 24,200 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 32,000 | $35.54 | $1,137,280.00 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 10 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,980,899 Underlying: Class A Common Stock · 32,000 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 7,708 | $36.59 | $282,049.59 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 9 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012,899 Underlying: Class A Common Stock · 7,708 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 24,000 | $36.32 | $871,792.80 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 8 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,020,607 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 900 | $37.21 | $33,489.99 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 7 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,044,607 Underlying: Class A Common Stock · 900 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 29,571 | $36.65 | $1,083,753.49 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 6 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,045,507 Underlying: Class A Common Stock · 29,571 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 23,744 | $36.26 | $860,912.33 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 5 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,075,078 Underlying: Class A Common Stock · 23,744 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 23, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 43,700 | $37.16 | $1,624,014.36 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 4 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,098,822 Underlying: Class A Common Stock · 43,700 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 22, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 577 | $38.62 | $22,282.64 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 3 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,142,522 Underlying: Class A Common Stock · 577 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 22, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 35,600 | $38.60 | $1,374,035.40 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 2 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,143,099 Underlying: Class A Common Stock · 35,600 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| March 20, 2017 Filed Mar 28, 2017 20:16 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass B Common Stock · Derivative | 15,908 | $38.90 | $618,892.79 |
DisclosureSEC source: 0001104659-17-019678 · a4.xml · derivative · entry 1 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178,699 Underlying: Class A Common Stock · 15,908 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock converts automatically into one share of Class A Common Stock upon any transfer. F1 · derivative.expiration_date: The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date. Read SEC document |
| February 01, 2017 Filed Feb 1, 2017 18:16 UTC | Jounce Therapeutics, Inc. JNCE · Entity 15754 | ConversionSeries B Convertible Preferred Stock · Derivative | 2,654,867 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-002381 · doc4.xml · derivative · entry 2 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 719,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. F1 · derivative.exercise_date: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. F1 · derivative.expiration_date: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. F1 · derivative.underlying_shares: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. Read SEC document |
| February 01, 2017 Filed Feb 1, 2017 18:16 UTC | Jounce Therapeutics, Inc. JNCE · Entity 15754 | ConversionCommon Stock | 719,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-002381 · doc4.xml · nonDerivative · entry 1 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. F1 · balance_after: Each share of Series B convertible preferred stock converted into 0.271003 shares of common stock immediately prior to the amendment and restatement by Jounce Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date. Read SEC document |
| October 24, 2016 Filed Oct 24, 2016 18:58 UTC | CRISPR Therapeutics AG CRSP · Entity 3852 | ConversionSeries B Convertible Preferred Shares · Derivative | 744,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-151611 · a4.xml · derivative · entry 2 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 744,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. F1 · derivative.exercise_date: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. F1 · derivative.expiration_date: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. Read SEC document |
| October 24, 2016 Filed Oct 24, 2016 18:58 UTC | CRISPR Therapeutics AG CRSP · Entity 3852 | ConversionCommon Shares | 744,380 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-151611 · a4.xml · nonDerivative · entry 1 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 21:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | ConversionClass B Common Stock · Derivative | 3,194,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-146571 · a4.xml · derivative · entry 2 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,194,607 Underlying: Class A Common Stock · 3,194,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date F1 · derivative.exercise_date: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date F1 · derivative.expiration_date: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 21:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | ConversionSeries C Convertible Preferred Stock · Derivative | 9,583,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-146571 · a4.xml · derivative · entry 1 Hadley Harbor Master Investors (Cayman) L.P. · CIK 0001641080 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,194,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date F1 · derivative.exercise_date: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date F1 · derivative.expiration_date: The Series C Convertible Preferred Stock converted into Class B Common Stock on a one-for-three basis and had no expiration date. The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis and has no expiration date Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.